Published online before print February 5, 2004, doi: 10.1161/01.ATV.0000120374.59826.1b
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Brief Reviews |
Brain Cholesterol: Long Secret Life Behind a Barrier
From the Division of Clinical Chemistry, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Correspondence to Dr Ingemar Björkhem, Division of Clinical Chemistry, Huddinge University Hospital, S-141 86, Sweden. E-mail ingemar.bjorkhem{at}hs.se
Although an immense knowledge has accumulated concerning regulation of cholesterol homeostasis in the body, this does not include the brain, where details are just emerging. Approximately 25% of the total amount of the cholesterol present in humans is localized to this organ, most of it present in myelin. Almost all brain cholesterol is a product of local synthesis, with the blood-brain barrier efficiently protecting it from exchange with lipoprotein cholesterol in the circulation. Thus, there is a highly efficient apolipoprotein-dependent recycling of cholesterol in the brain, with minimal losses to the circulation. Under steady-state conditions, most of the de novo synthesis of cholesterol in the brain appears to be balanced by excretion of the cytochrome P-450-generated oxysterol 24S-hydroxycholesterol. This oxysterol is capable of escaping the recycling mechanism and traversing the blood-brain barrier. Cholesterol levels and cholesterol turnover are affected in neurodegenerating disorders, and the capacity for cholesterol transport and recycling in the brain seems to be of importance for the development of such diseases. The possibility has been discussed that administration of inhibitors of cholesterol synthesis may reduce the prevalence of Alzheimer disease. No firm conclusions can, however, be drawn from the studies presented thus far. In the present review, the most recent advances in our understanding of cholesterol turnover in the brain is discussed.
Key Words: brain cholesterol • blood-brain barrier • cholesterol 24S-hydroxylase • Alzheimer disease • statins
This article has been cited by other articles:
 |
|
 |
|
  D. H. Kim and J. A. Frangos Effects of Amyloid {beta}-Peptides on the Lysis Tension of Lipid Bilayer Vesicles Containing Oxysterols Biophys. J., July 15, 2008; 95(2): 620 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sura, R. Sura, A. E. EnayetAllah, and D. F. Grant Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain J. Histochem. Cytochem., June 1, 2008; 56(6): 551 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Wang, L. Yvan-Charvet, D. Lutjohann, M. Mulder, T. Vanmierlo, T.-W. Kim, and A. R. Tall ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain FASEB J, April 1, 2008; 22(4): 1073 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Infante, L. Abi-Mosleh, A. Radhakrishnan, J. D. Dale, M. S. Brown, and J. L. Goldstein Purified NPC1 Protein: I. BINDING OF CHOLESTEROL AND OXYSTEROLS TO A 1278-AMINO ACID MEMBRANE PROTEIN J. Biol. Chem., January 11, 2008; 283(2): 1052 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Valenza, J. B. Carroll, V. Leoni, L. N. Bertram, I. Bjorkhem, R. R. Singaraja, S. Di Donato, D. Lutjohann, M. R. Hayden, and E. Cattaneo Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation Hum. Mol. Genet., September 15, 2007; 16(18): 2187 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guizzetti, J. Chen, J. F. Oram, R. Tsuji, K. Dao, T. Moller, and L. G. Costa Ethanol Induces Cholesterol Efflux and Up-regulates ATP-binding Cassette Cholesterol Transporters in Fetal Astrocytes J. Biol. Chem., June 29, 2007; 282(26): 18740 - 18749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Panzenboeck, U. Andersson, M. Hansson, W. Sattler, S. Meaney, and I. Bjorkhem On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis J. Lipid Res., May 1, 2007; 48(5): 1167 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kurumada, A. Onishi, H. Imai, K. Ishii, T. Kobayashi, and S. B. Sato Stage-Specific Association of Apolipoprotein A-I and E in Developing Mouse Retina Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1815 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guizzetti and L. Costa Cholesterol homeostasis in the developing brain: a possible new target for ethanol Human and Experimental Toxicology, April 1, 2007; 26(4): 355 - 360. [Abstract] [PDF]
|
|
|
|
|
|
S. Meaney, M. Heverin, U. Panzenboeck, L. Ekstrom, M. Axelsson, U. Andersson, U. Diczfalusy, I. Pikuleva, J. Wahren, W. Sattler, et al. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid J. Lipid Res., April 1, 2007; 48(4): 944 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, J. Tuomilehto, H. Soininen, and M. Kivipelto Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study Neurology, March 6, 2007; 68(10): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Wasser, M. Ertunc, X. Liu, and E. T. Kavalali Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling J. Physiol., March 1, 2007; 579(2): 413 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abildayeva, P. J. Jansen, V. Hirsch-Reinshagen, V. W. Bloks, A. H. F. Bakker, F. C. S. Ramaekers, J. de Vente, A. K. Groen, C. L. Wellington,, F. Kuipers, et al. 24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux J. Biol. Chem., May 5, 2006; 281(18): 12799 - 12808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Kotti, D. M. O. Ramirez, B. E. Pfeiffer, K. M. Huber, and D. W. Russell Brain cholesterol turnover required for geranylgeraniol production and learning in mice PNAS, March 7, 2006; 103(10): 3869 - 3874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al. Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES J. Biol. Chem., February 17, 2006; 281(7): 3810 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, J. B. Shofer, W. A. Kukull, E. R. Peskind, D. W. Tsuang, J.C.S. Breitner, W. McCormick, J. D. Bowen, L. Teri, G. D. Schellenberg, et al. Serum cholesterol and risk of Alzheimer disease: A community-based cohort study Neurology, October 11, 2005; 65(7): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yoshida and Y. Wada Transfer of maternal cholesterol to embryo and fetus in pregnant mice J. Lipid Res., October 1, 2005; 46(10): 2168 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Reiss Cholesterol and apolipoprotein E in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 91 - 96. [Abstract] [PDF]
|
|